MESOTHELIN AS A BIOMARKER AND THERAPEUTIC TARGET IN CHEMOTHERAPY-RESISTANT EARLY LUNG ADENOCARCINOMA (LAC)

Sloan-Kettering Institute For Cancer Research

Investigators